TGTX TG Therapeutics Inc

P/E 19.7

Forward P/E 25.84

Price/Sales 10.37

Beta 1.799

Div Yield --

Market Cap --

Company Analysis

Latest News

November 01, 2026

TG Therapeutics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 02, 2026

TG Therapeutics is expected to report Q3 2026 revenue of $245.47 million and EPS of $0.37, while the stock currently trades at $61.18 against an average...